Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primidone for Parkinson's disease
ChiCTR2300069580Phase 4Not yet recruiting
- Sponsor
- Yichang First People's Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of primidone in Parkinson's disease (PD) (3 arms), sponsored by Yichang First People's Hospital. Primary endpoints: Receptor interaction serine/threonine protein kinase-1 (RIPK1), Receptor interaction serine/threonine protein kinase-3 (RIPK3) and 8 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
primidone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR2300069580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069580.